Sorrento Therapeutics Inc...

AI Score

0

Unlock

0.00
-0.00 (-100.00%)
At close: Mar 03, 2025, 3:53 PM
0.00
-57.14%
Pre-market: Jan 02, 2025, 09:30 AM EST

Sorrento Therapeutics Cash Flow Statement

Year FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Net Income -577.76M -429.14M -314.41M -363.01M -203.54M 9.06M -60.92M -50.07M -34.66M -21.91M -4.85M -3.24M -1.81M -942.27K -188.9K -270.62K -439.29K 308.03K -763 -763
Depreciation & Amortization 13.24M 12.46M 11.01M 10.99M 9.05M 7.08M 2.88M 2.37M 3.18M 1.29M 293.3K 159.22K 23.41K 2.75K n/a n/a n/a n/a n/a n/a
Stock-Based Compensation 74.85M 90.19M 31.42M 12.65M n/a 4.95M 4.74M 6.97M 3.94M 1.79M 863.13K 298.03K 250.95K 54.52K n/a n/a n/a n/a n/a n/a
Other Working Capital 74.87M -4.57M -1.68M -2.97M 4.04M -18.68M 22.3M 9.88M 275K -557.43K -66.9K -7.08K 121.82K 5.41K -14.06K n/a n/a -298.49K n/a 763.00
Other Non-Cash Items 128.09M 83.39M 110.77M 159.5M 98.99M -48.96M -36.85M -49.48M 693K 1.9M n/a -3.24M n/a n/a n/a 71K n/a n/a n/a n/a
Deferred Income Tax -1.84M -35.93M -2.13M -373K -6.12M -35.68M 982K 33.34M -1.7M n/a n/a 3.24M n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital 69.55M -2.79M 3.8M 7.25M 6M -17.6M 25.54M 14.8M -222K 437.97K -108.6K 35.86K -12.8K 150.02K -15.02K -468.5K 439.29K -298.49K 763.00 763.00
Operating Cash Flow -293.86M -281.82M -159.54M -173M -111.77M -99.18M -70.89M -42.07M -28.76M -16.49M -3.8M -2.74M -1.55M -734.96K -203.92K -668.12K n/a 9.54K n/a n/a
Capital Expenditures -13.66M -8.87M -37.58M -11.44M -21.2M -10.97M -6.86M -3.71M -591K -931.3K -547.88K -1.05M -46.03K -45.52K n/a n/a n/a n/a n/a n/a
Acquisitions -14.86M -36.05M -2.34M -9.69M n/a -557K -9.84M 27.76M n/a 427.82K n/a n/a n/a 104.86K n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a -35.3M -2.34M -9.69M n/a -5M -750K -11.5M -10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a 124.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a -17.04M -10M n/a n/a n/a n/a -83.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -28.52M 79.85M -39.92M -38.17M -21.2M -16.53M -17.45M 12.55M -10.59M -503.48K -547.88K -1.05M -46.03K 59.34K n/a n/a n/a n/a n/a n/a
Debt Repayment -92.24M -35.91M -186.98M 22.34M 242.18M -3.24M 38.87M -3.1M 7.5M 6.85M n/a n/a n/a n/a n/a n/a n/a -9.54K n/a n/a
Common Stock Repurchased n/a n/a -55M n/a n/a n/a -15.64M n/a n/a n/a n/a -43 n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 1.62M 15.42M 98.35M 8.85M 211K -1.01M 524K -252K 304K -982.49K 36.12K 13.13K n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow 311.72M 181.33M 174.24M 78.89M 326M 53.67M 131.74M -3.35M 79.59M 43.57M 5.97M 1.98M 3.44M 4.11M 562.5K 690K n/a -9.54K n/a n/a
Net Cash Flow -13.03M -19.8M -24.3M -132.56M 147.9M -61.97M 43.36M -32.86M 40.23M 26.58M 1.62M -1.81M 1.85M 4.11M 358.58K 21.88K n/a n/a n/a n/a
Free Cash Flow -307.51M -290.69M -197.12M -184.44M -132.96M -110.15M -77.75M -45.78M -29.36M -17.42M -4.35M -3.8M -1.59M -780.49K -203.92K -668.12K n/a 9.54K n/a n/a